Pennant Group Chief Clinical Officer Jason Paul Steik sells 1,394 shares for $53,700.67
PNTG•Insider sale details
- Pennant Group Chief Clinical Officer Jason Paul Steik sold 1,394 common shares on Aug. 6.
- Shares were sold at $38.52 each; direct holding fell to 15,106 shares.
